newsfilter
← Latest News
PR Newswire·

Bausch Health Provides Update on RED-C Phase 3 Clinical Trials

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced the results of the global Phase 3 RED-C clinical program evaluating...